文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

机械通气ICU患者吞咽障碍(DYnAMICS):一项前瞻性观察性试验

Dysphagia in Mechanically Ventilated ICU Patients (DYnAMICS): A Prospective Observational Trial.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论拔管后吞咽障碍发生率为12.4%,是28天和90天死亡的独立预测因素(校正后90天超额死亡率9.2%),应重视拔管后吞咽筛查。

该前瞻性观察性试验在三级学术中心ICU对1304例次混合成人ICU患者进行拔管后吞咽障碍筛查,主要分析933例次首次ICU入住。拔管后3小时内由受训ICU护士床旁筛查,阳性者24小时内由专科医师确认。拔管后吞咽障碍筛查阳性率12.4%(急诊患者18.3%,择期患者4.9%),ICU出院时吞咽障碍发生率10.3%,其中60.4%持续至出院。吞咽障碍患者喂养管天数、机械通气时间、ICU/住院时间及住院死亡率均更高(均p<0.001),校正疾病严重度和机械通气时间后仍是28天和90天死亡的独立预测因素(90天超额死亡率9.2%)。

要点

  • 拔管后3小时内由受训ICU护士行床旁吞咽筛查,阳性者24小时内由专科医师确认;筛查阳性率12.4%(116/933)。
  • 急诊患者拔管后吞咽障碍筛查阳性率18.3%,择期患者4.9%;ICU出院时吞咽障碍发生率10.3%(96/933),其中60.4%持续至出院。
  • 吞咽障碍患者喂养管天数、机械通气时间、ICU/住院时间及住院死亡率均更高(均p<0.001)。
  • 吞咽障碍是28天和90天死亡的独立预测因素,校正疾病严重度和机械通气时间后90天超额死亡率为9.2%。
  • 作者认为拔管后吞咽障碍可能是一个被忽视的问题,针对其病因和治疗干预的研究似乎有必要。

适用人群与场景

  • 混合成人ICU患者,中位年龄66.0岁(四分位距54.0-74.0),APACHE-II评分19.0(四分位距14.0-24.0)。
  • 共筛查1304例次入住,主要分析933例次首次ICU入住,随访至90天或死亡;另设独立学术中心确认队列220例。

诊断标准与关键阈值

  • 床旁吞咽障碍筛查在拔管后3小时内由受训ICU护士完成,阳性筛查触发专科医师床旁吞咽确认检查。
  • 阳性筛查后24小时内由专科医师确认,确认率87.3%(96/110,6例数据缺失)。

研究设计与关键结果

  • 前瞻性观察性试验,主要分析933例次首次ICU入住,另设独立学术中心确认队列220例。
  • 拔管后吞咽障碍筛查阳性率12.4%(116/933),急诊患者18.3%、择期患者4.9%。
  • ICU出院时吞咽障碍发生率10.3%(96/933),其中60.4%(58/96)持续至出院。
  • 吞咽障碍患者喂养管天数、机械通气时间、ICU/住院时间及住院死亡率均更高(均p<0.001)。
  • 吞咽障碍90天死亡单变量风险比3.74(95%CI 2.01-6.95;p<0.001)。
  • 校正疾病严重度和机械通气时间后,吞咽障碍仍是28天和90天死亡的独立预测因素,90天超额死亡率9.2%。

证据类型、等级与局限

  • 证据类型:前瞻性观察性试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为拔管后吞咽障碍可能是一个被忽视的问题,针对其病因和治疗干预的研究似乎有必要。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Swallowing disorders may be associated with adverse clinical outcomes in patients following invasive mechanical ventilation. We investigated the incidence of dysphagia, its time course, and association with clinically relevant outcomes in extubated critically ill patients.

DESIGN: Prospective observational trial with systematic dysphagia screening and follow-up until 90 days or death.

SETTINGS: ICU of a tertiary care academic center.

PATIENTS: One thousand three-hundred four admissions of mixed adult ICU patients (median age, 66.0 yr [interquartile range, 54.0-74.0]; Acute Physiology and Chronic Health Evaluation-II score, 19.0 [interquartile range, 14.0-24.0]) were screened for postextubation dysphagia. Primary ICU admissions (n = 933) were analyzed and followed up until 90 days or death. Patients from an independent academic center served as confirmatory cohort (n = 220).

INTERVENTIONS: Bedside screening for dysphagia was performed within 3 hours after extubation by trained ICU nurses. Positive screening triggered confirmatory specialist bedside swallowing examinations and follow-up until hospital discharge.

MEASUREMENTS AND MAIN RESULTS: Dysphagia screening was positive in 12.4% (n = 116/933) after extubation (18.3% of emergency and 4.9% of elective patients) and confirmed by specialists within 24 hours from positive screening in 87.3% (n = 96/110, n = 6 missing data). The dysphagia incidence at ICU discharge was 10.3% (n = 96/933) of which 60.4% (n = 58/96) remained positive until hospital discharge. Days on feeding tube, length of mechanical ventilation and ICU/hospital stay, and hospital mortality were higher in patients with dysphagia (all p < 0.001). The univariate hazard ratio for 90-day mortality for dysphagia was 3.74 (95% CI, 2.01-6.95; p < 0.001). After adjustment for disease severity and length of mechanical ventilation, dysphagia remained an independent predictor for 28-day and 90-day mortality (excess 90-d mortality 9.2%).

CONCLUSIONS: Dysphagia after extubation was common in ICU patients, sustained until hospital discharge in the majority of affected patients, and was an independent predictor of death. Dysphagia after mechanical ventilation may be an overlooked problem. Studies on underlying causes and therapeutic interventions seem warranted.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Schefold JC, Berger D, Zürcher P, et al. Dysphagia in Mechanically Ventilated ICU Patients (DYnAMICS): A Prospective Observational Trial. Crit Care Med. 2017. PMID: 29023260. doi:10.1097/CCM.0000000000002765

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。